Spotlight on Metastatic Breast Cancer
In 2024 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
16-22 of 22
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Project Oncology®Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Project Oncology®Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Project Oncology®Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Project Oncology®Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Project Oncology®The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Treating Metastatic Breast Cancer: Where Are We Now?
Project Oncology®Treating Metastatic Breast Cancer: Where Are We Now?
- advertisement
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
Project Oncology®A Look at the Therapeutic Landscape for Metastatic Breast Cancer
